The General Insurance Council has proposed a 10% mandatory co-payment on health insurance policies starting January 1, 2027, capped at Rs 5 lakh per claim. Aimed at curbing rising hospital billing inflation and unnecessary medical procedures, the move could lead to lower premiums. However, the proposal faces scrutiny regarding consumer choice and potential competition concerns. Investors will monitor how this shapes the long-term profitability and demand for health insurance products.
The general insurance sector in India is moving toward a structural change that could fundamentally alter how health insurance claims are settled. The General Insurance Council is deliberating a proposal to mandate a 10% co-payment for policyholders on all admissible hospitalization claims. If implemented by the target date of January 1, 2027, this rule would apply to retail indemnity and group policies, with the policyholder's contribution capped at Rs 5 lakh per claim.
This shift is primarily designed to address the issue of provider-induced billing inflation. Insurers argue that the current model of comprehensive coverage often leads to inefficiencies in the healthcare system, as policyholders remain largely shielded from immediate medical costs. According to the industry, this lack of price sensitivity can encourage hospitals to suggest redundant diagnostic tests or longer-than-necessary patient stays. By requiring patients to pay 10% of their bills, insurers hope to align the financial incentives of the policyholder with the necessity of the medical services provided.
Beyond the co-payment rule, the proposal includes a plan to expand and standardize hospital networks. The council is working to increase the count of empanelled hospitals to 5,000, while implementing common pricing benchmarks and formal mechanisms to settle disputes between insurers and healthcare providers. This standardization is intended to create more predictability in claim amounts and stabilize annual premiums across the market.
However, the proposal faces significant challenges. Consumer advocates have expressed concern that eliminating full-coverage policy options could negatively impact those who pay higher premiums specifically for comprehensive protection. There is also a risk of regulatory pushback; if the industry acts collectively to standardize these terms, it could draw scrutiny from the Competition Commission of India regarding anti-competitive practices and the limitation of consumer choice.
For the insurance industry, this is a delicate balancing act. While the move could improve profit margins by reducing excessive claims, the risk lies in potentially discouraging customers from purchasing high-value health insurance plans due to the added out-of-pocket burden. The ultimate impact on the sector will depend on how the regulator views the balance between cost-containment measures and consumer protection. Market participants and investors will be tracking the next developments regarding official regulatory approvals and whether the industry can successfully implement these changes without a negative impact on market demand.